IRCT2016100914106N5CompletedPhase 2
Preparation an oral gel-made from thymoquinone (TQ), and clinical study investigating the efficacy of it on patients with aphtha
Vice chancellor for research, Kermanshah University of Medical Science0 sites56 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 56
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Patient inclusion criteria include: possessing aphtatous ulcer; patients without systemic diseases, hypersensitivity history; smoking habits or alcoholism; pregnancy and lactation; orthodontic instruments.
- •Patient exclusion criteria include: Drug usage or any treatment occurring before dental treatment.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
Therapeutic effects of oral gel-produced from peel of pomegranate in patients with recurrent aphthous stomatitisRecurrent Aphthous Stomatitis.Recurrent oral aphthaeIRCT2016092414106N3Vice chancellor for research, Kermanshah University of Medical Science56
Recruiting
Phase 3
Formulation of a topical gel containing Lawsonia inermis and Aloe vera and evaluation its effects on radiation-induced dermatitisDermatitis.Dermatitis, unspecifiedL30.9IRCT20191106045356N7Yazd University of Medical Sciences56
Recruiting
Phase 3
Formulation of a topical gel containing Lawsonia inermis and Crocin and evaluation its effects on preventing radiation-induced dermatitis.Dermatitis.Dermatitis, unspecifiedL30.9IRCT20191106045356N20Yazd University of Medical Sciences56
Not yet recruiting
Phase 1
Yiqing oral liquid in the treatment of novel coronavirus infection randomized controlled clinical studiesITMCTR2200005961Huashan Hospital Affiliated to Fudan University
Not yet recruiting
Phase 3
Preparation of sticky mucus gel containing Nigella sativa extract, comparison and evaluation of its clinical effect with Clotrimazole vaginal cream 1% for the treatment of vulvovaginal candidiasis.IRCT20220510054813N1Zanjan University of Medical Sciences102